Description
This session offers an inside look at the growing interest in Grid in the pharmaceutical industry and the healthcare sector, showcasing the successful deployment of EGEE's programme for Biomedicine and Bio-informatics. Presentations evaluate the benefits of Grid for pharmaceutical firms & biotechs, as well as hospitals as natural candidates for Grid adoption with reference to drug discovery, medical imaging, data management and workflows.
-
Falk Zimmermann (NEC Labs Europe)02/10/2007, 11:00The goal of the SIMDAT Pharma application activity is to demonstrate the usefulness of Grid technology in the area of life sciences. We implement an industrial strength pharmaceutical workflow across a Grid test-bed comprised of both academic and industrial partners. Naturally, these different types of partners are operating their Grid node with different security and quality of services...Go to contribution page
-
Mr David Manset (Maat Gknowledge)02/10/2007, 11:20Health-e-Child (pronounced healthy child) is an attempt to respond to the increasingly pressing demand to fully integrate and exploit heterogeneous biomedical information for improved clinical practice, medical research, and personalized healthcare. As an integrated project of the Sixth Framework Programme of the European Commission, the project brings together three major paediatric centres...Go to contribution page
-
Yannick Legre (CNRS)02/10/2007, 11:40